Nathan Mohar (Wallrath Lab) gave an oral presentation titled "DNA sequence variation in SMAD7 enhances LMNA-associated skeletal muscle disease and implicates SMAD signaling as a therapeutic target" at the 2024 Muscular Dystrophy Association Clinical and Scientific Conference held in Orlando, Florida from March 3 - 6.